ArticleClinical pharmacology and therapeutics2022

CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes.

Ke Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.